Ortin Laboratories Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Ortin Laboratories Ltd?

Ortin Laboratories Ltd is trading at 20.10 as of 20 April 2026, with a FY2026-2027 high of 26.4 and low of 16.2. The stock is currently in the middle of its 52-week range. Market cap stands at 16.4 Cr..

Q: Is Ortin Laboratories Ltd financially healthy?

Key indicators: ROCE of 60.2 % indicates efficient capital utilization. Dividend yield is 0.00 %.

Q: Is Ortin Laboratories Ltd profitable and how is the profit trend?

Ortin Laboratories Ltd reported a net profit of -8 Cr in Mar 2024 on revenue of 2 Cr. Compared to 1 Cr in Mar 2021, the net profit shows a declining trend.

Fair Value

₹50.12Undervalued by 149.35%vs CMP ₹20.10

P/E (15.0) × ROE (118.0%) × BV (₹3.47) × DY (2.00%)

Defaults: P/E=15

₹16.79Overvalued by 16.47%vs CMP ₹20.10

MoS: -19.7% (Negative)Confidence: 44/100 (Low)Models: 1 Under, 3 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹31.28	39%	Under (+55.6%)
Net Asset Value	Assets	₹3.46	24%	Over (-82.8%)
ROCE Capital	Returns	₹16.41	20%	Over (-18.4%)
Revenue Multiple	Revenue	₹2.79	18%	Over (-86.1%)
Consensus (4 models)		₹16.79	100%	Overvalued

Key Drivers: EPS CAGR -37.6% drags value — could be higher if earnings stabilize. | Wide model spread (₹3–₹31) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -37.6% · Defaults: P/E=15

*Investments are subject to market risks

Analyst Summary

Ortin Laboratories Ltd operates in the Pharmaceuticals segment, NSE: ORTINLAB | BSE: 539287, current market price is ₹20.10, market cap is 16.4 Cr.. At a glance, ROE is 118 %, ROCE is 60.2 %, book value is 3.47, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹16.79, around 16.5% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹2 Cr versus the prior period change of -62.0%, while latest net profit is about ₹-8 Cr with a prior-period change of -8,833.3%. This analysis page also carries profit and loss, ratio panels data, which improves the depth of the template beyond a thin price-only snapshot. The 52-week range shown on this page is 26.4/16.2, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisOrtin Global Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885. Currently Company is involved…

This summary is generated from the stock page data available for Ortin Laboratories Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Ortin Laboratories Ltd scores 47/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health59/100 · Moderate

ROCE 60.2% ExcellentROE 118.0% ExcellentD/E 0.58 ModerateInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent

Smart Money50/100 · Moderate

Earnings Quality40/100 · Moderate

OPM contracting (10% → -135%) Declining

Quarterly Momentum25/100 · Weak

Revenue (4Q): -62% YoY DecliningOPM: -1,016.7% (down 1,014.7% YoY) Margin pressure

Industry Rank65/100 · Strong

ROCE 60.2% vs industry 16.4% Above peersROE 118.0% vs industry 15.2% Above peers3Y sales CAGR: -35% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: September 3, 2024, 11:03 pm

Market Cap	16.4 Cr.
Current Price	20.1
Intrinsic Value	₹16.79
High / Low	26.4/16.2
Stock P/E
Book Value	3.47
Dividend Yield	0.00 %
ROCE	60.2 %
ROE	118 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Ortin Laboratories Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	106 Cr.	84.2	137/76.0	21.9	49.6	0.00 %	12.9 %	9.69 %	10.0
MPS Pharmaa Ltd	3.15 Cr.	1.65	3.17/1.57		0.33	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	2,692 Cr.	247	479/222	56.3	24.3	0.27 %	27.3 %	21.7 %	1.00
Gujarat Terce Laboratories Ltd	25.3 Cr.	32.5	68.4/29.0		10.1	0.00 %	41.4 %	14.6 %	10.0
Gujarat Inject (Kerala) Ltd	120 Cr.	82.1	82.1/17.0	481	6.93	0.00 %	13.5 %	11.0 %	10.0
Industry Average	19,815.15 Cr	1,053.84		53.84	201.20	0.39%	16.35%	15.16%	6.10

All Competitor Stocks of Ortin Laboratories Ltd

Quarterly Result

Metric	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Sales	1.76	1.98	2.29	1.66	2.45	2.62	0.79	1.17	1.49	1.57	0.27	0.14	0.30
Expenses	1.55	1.61	2.00	1.65	2.59	2.41	1.01	0.55	1.52	1.39	1.17	2.74	3.35
Operating Profit	0.21	0.37	0.29	0.01	-0.14	0.21	-0.22	0.62	-0.03	0.18	-0.90	-2.60	-3.05
OPM %	11.93%	18.69%	12.66%	0.60%	-5.71%	8.02%	-27.85%	52.99%	-2.01%	11.46%	-333.33%	-1,857.14%	-1,016.67%
Other Income	0.05	0.00	0.04	0.00	0.00	0.00	0.00	0.00	-0.03	0.00	0.00	0.00	0.00
Interest	0.19	0.18	0.19	0.19	0.24	0.10	0.09	0.10	0.12	0.11	0.15	0.14	0.08
Depreciation	0.07	0.07	0.07	-0.07	0.23	0.07	0.07	0.07	0.03	0.06	0.06	0.06	0.05
Profit before tax	0.00	0.12	0.07	-0.11	-0.61	0.04	-0.38	0.45	-0.21	0.01	-1.11	-2.80	-3.18
Tax %		25.00%	28.57%	-18.18%	-24.59%	1,150.00%	-121.05%	0.00%	-4.76%	0.00%	1.80%	-0.71%	30.19%
Net Profit	0.80	0.09	0.05	-0.09	-0.45	-0.43	0.08	0.46	-0.20	0.02	-1.12	-2.79	-4.14
EPS in Rs	0.98	0.11	0.06	-0.11	-0.55	-0.53	0.10	0.57	-0.25	0.02	-1.38	-3.43	-5.09

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	74.74	67.00	60.29	62.72	61.57	79.63	167.51	197.36	8.16	8.23	6.00	2.28
Expenses	68.17	60.90	53.80	56.83	56.12	74.22	160.83	191.66	6.92	7.85	5.47	8.65
Operating Profit	6.57	6.10	6.49	5.89	5.45	5.41	6.68	5.70	1.24	0.38	0.53	-6.37
OPM %	8.79%	9.10%	10.76%	9.39%	8.85%	6.79%	3.99%	2.89%	15.20%	4.62%	8.83%	-279.39%
Other Income	0.24	0.81	0.00	0.57	0.32	0.45	0.13	0.18	0.05	0.19	0.01	0.00
Interest	3.55	3.72	3.52	3.42	2.94	3.49	3.22	3.21	0.87	0.81	0.40	0.48
Depreciation	1.40	1.51	1.64	1.65	1.70	1.69	1.75	1.96	0.29	0.29	0.25	0.23
Profit before tax	1.86	1.68	1.33	1.39	1.13	0.68	1.84	0.71	0.13	-0.53	-0.11	-7.08
Tax %	41.40%	29.17%	32.33%	41.01%	55.75%	0.00%	30.43%	181.69%	-623.08%	-24.53%	-18.18%	13.56%
Net Profit	1.09	1.19	0.90	0.83	0.50	0.68	1.28	-0.56	0.95	-0.40	-0.09	-8.04
EPS in Rs	0.64	0.70	0.53	0.49	0.30	0.40	0.76	-0.33	1.17	-0.49	-0.11	-9.89
Dividend Payout %	38.85%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	9.17%	-24.37%	-7.78%	-39.76%	36.00%	88.24%	-143.75%	269.64%	-142.11%	77.50%	-8833.33%
Change in YoY Net Profit Growth (%)	0.00%	-33.54%	16.59%	-31.98%	75.76%	52.24%	-231.99%	413.39%	-411.75%	219.61%	-8910.83%

Ortin Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: Unknown

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	8.13	8.13	8.13	8.13
Reserves	3.84	5.02	5.50	6.33	6.46	7.14	8.15	6.88	3.22	2.83	2.73	-5.31
Borrowings	17.92	18.68	20.96	20.85	17.34	17.34	19.47	19.57	6.94	6.14	6.45	1.80
Other Liabilities	34.80	31.93	23.87	21.22	20.79	32.24	60.53	73.13	2.97	3.61	3.89	1.97
Total Liabilities	73.50	72.57	67.27	65.34	61.53	73.66	105.09	116.52	21.26	20.71	21.20	6.59
Fixed Assets	24.77	23.90	21.83	21.63	20.69	20.03	21.29	22.45	14.38	14.21	13.96	0.01
CWIP	0.00	0.00	0.00	0.00	0.35	0.40	0.53	0.43	0.43	0.43	0.43	0.00
Investments	0.03	0.03	0.03	0.03	0.07	0.08	0.08	0.07	0.00	0.00	0.00	0.00
Other Assets	48.70	48.64	45.41	43.68	40.42	53.15	83.19	93.57	6.45	6.07	6.81	6.58
Total Assets	73.50	72.57	67.27	65.34	61.53	73.66	105.09	116.52	21.26	20.71	21.20	6.59

Reserves and Borrowings Chart

Cash Flow - No data available for this post.

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-11.35	-12.58	-14.47	-14.96	-11.89	-11.93	-12.79	-13.87	-5.70	-5.76	-5.92	-8.17

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

No data available for the Financial Efficiency data table.

Financial Efficiency Indicators Chart

No data available for the Shareholding

No data available for the Shareholding Pattern chart.

No data available for the No. of Shareholders chart.

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 12
FaceValue	10.00
Basic EPS (Rs.)	2.73
Diluted EPS (Rs.)	2.73
Cash EPS (Rs.)	3.59
Book Value[Excl.RevalReserv]/Share (Rs.)	14.47
Book Value[Incl.RevalReserv]/Share (Rs.)	14.47
Revenue From Operations / Share (Rs.)	50.63
PBDIT / Share (Rs.)	6.99
PBIT / Share (Rs.)	6.13
PBT / Share (Rs.)	4.20
Net Profit / Share (Rs.)	2.73
NP After MI And SOA / Share (Rs.)	2.73
PBDIT Margin (%)	13.81
PBIT Margin (%)	12.10
PBT Margin (%)	8.30
Net Profit Margin (%)	5.38
NP After MI And SOA Margin (%)	5.38
Return on Networth / Equity (%)	18.85
Return on Capital Employeed (%)	34.77
Return On Assets (%)	5.67
Long Term Debt / Equity (X)	0.11
Total Debt / Equity (X)	0.58
Current Ratio (X)	1.11
Quick Ratio (X)	0.82
Interest Coverage Ratio (X)	3.63
Interest Coverage Ratio (Post Tax) (X)	2.42
Enterprise Value (Cr.)	62.39
EV / Net Operating Revenue (X)	0.72
EV / EBITDA (X)	5.27
MarketCap / Net Operating Revenue (X)	0.56
Price / BV (X)	1.97
Price / Net Operating Revenue (X)	0.56
EarningsYield	0.09

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Ortin Global Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 0.34 Cr. and Equity Capital is Rs. 8.13 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	D. No: 1-8-305, Ground Floor, Chikkadpally, Hyderabad Telangana 500020	Contact not found

Management
Name	Position Held
Mr. Sarang Balbhimrao Patodekar	Chairperson & Independent Director
Mr. Murali Krishna Murthy Sanka	Managing Director
Mrs. Prakruti Prashant Sawant	Whole Time Director
Mr. Prashant Prakash Sawant	Whole Time Director
Mr. Pramod Dnyandeo Waghe	Non Executive Director
Mr. Shashikant Shankarrao Igave	Non Executive Director
Mr. Ajay Vishwakarma	Independent Director
Ms. Mounika Pammi	Independent Director

FAQ

What is the intrinsic value of Ortin Laboratories Ltd and is it undervalued?

As of 20 April 2026, Ortin Laboratories Ltd's intrinsic value is ₹16.79, which is 16.47% lower than the current market price of ₹20.10, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (118 %), book value (₹3.47), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Ortin Laboratories Ltd?

Ortin Laboratories Ltd is trading at ₹20.10 as of 20 April 2026, with a FY2026-2027 high of ₹26.4 and low of ₹16.2. The stock is currently in the middle of its 52-week range. Market cap stands at ₹16.4 Cr..

How does Ortin Laboratories Ltd's P/E ratio compare to its industry?

Ortin Laboratories Ltd has a P/E ratio of , which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Ortin Laboratories Ltd financially healthy?

Key indicators for Ortin Laboratories Ltd: ROCE of 60.2 % indicates efficient capital utilization; ROE of 118 % shows strong shareholder returns. Dividend yield is 0.00 %.

Is Ortin Laboratories Ltd profitable and how is the profit trend?

Ortin Laboratories Ltd reported a net profit of ₹-8 Cr in Mar 2024 on revenue of ₹2 Cr. Compared to ₹1 Cr in Mar 2021, the net profit shows a declining trend.

Does Ortin Laboratories Ltd pay dividends?

Ortin Laboratories Ltd has a dividend yield of 0.00 % at the current price of ₹20.10. The company is currently not paying meaningful dividends.